30 results

• Dupixent Injection Lawsuits Consolidated in MDL Over CTCL Diagnoses

  June 9, 2026

  Irvin Jackson

  The U.S. Judicial Panel on Multidistrict Litigation has consolidated all Dupixent lawsuits in the District of New Jersey for pretrial proceedings.

• Dupixent Injection Lawsuit Alleges Manufacturer Failed to Warn About T-Cell Lymphoma Cancer Side Effects

  June 4, 2026

  Irvin Jackson

  Regeneron and Sanofi-Aventis face a Dupixent injection lawsuit from a Louisiana woman who says the companies knew about the drug's risks but downplayed them to doctors and patients.

• Dupixent Cancer Lawsuit Claims Eczema Drug Caused Woman’s CTCL Diagnosis

  May 28, 2026

  Michael Adams

  A Delaware woman has filed a Dupixent lawsuit, claiming manufacturers promoted the eczema drug as a breakthrough treatment while failing to warn that it may trigger or worsen CTCL, a rare form of non-Hodgkin’s lymphoma.

• Link Between Dupixent and Cancer Withheld From Doctors and Users, Lawsuit Alleges

  May 11, 2026

  Michael Adams

  A lawsuit alleges an Illinois woman developed CTCL after using Dupixent, raising concerns the manufacturer may have withheld concerns that the drug could contribute to cancer.

• Lawsuit Indicates Dupixent Lymphoma Diagnosis Resulted in Multiple Rounds of Chemotherapy

  May 1, 2026

  Irvin Jackson

  A Dupixent lawsuit claims use of the drug led to the diagnosis of two forms of CTCL cancer, requiring repeated chemotherapy treatment and life-long medical monitoring.

• Judges Will Consider MDL for Dupixent Cancer Lawsuits Late Next Month

  April 21, 2026

  Irvin Jackson

  A group of federal judges will determine whether all Dupixent cancer lawsuits should be formed into a multidistrict litigation, following oral arguments set for May 28.

• Dupixent Injections Caused Peripheral T-Cell Lymphoma (PTCL) Diagnosis: Lawsuit

  April 6, 2026

  Irvin Jackson

  An Illinois man's Dupixent injection lawsuit claims manufacturers knew, or should have known, about the potential T-cell cancer risks, but hid those problems from the public.

• Link Between Dupixent and CTCL Withheld From Users, Medical Community: Lawsuit

  March 31, 2026

  Irvin Jackson

  A Dupixent lawsuit indicates the manufacturers failed to warn doctors and patients about the risks of T-cell lymphoma and other forms of cancer.

• Drug Makers Agree Dupixent Cancer Lawsuits Should Be Centralized in MDL

  March 26, 2026

  Irvin Jackson

  Regeneron and Sanofi-Aventis agree with calls to consolidate all Dupixent cancer lawsuits currently spread throughout the federal court system before one judge.

• Enlarged Lymph Nodes Led to Dupixent CTCL Diagnosis, Lawsuit Claims

  March 16, 2026

  Irvin Jackson

  The makers of Dupixent face a lawsuit from a Florida woman who says she developed CTCL after just a month of injections of the atopic dermatitis treatment.